Information Journal Paper
APA:
Copy. (2018). Safety and efficacy of nanocurcumin as addon therapy to riluzole in patients with amyotrophic lateral sclerosis: A pilot randomized clinical trial. NEUROTHERAPEUTICS, 15(-), 430-438. SID. https://sid.ir/paper/726327/en
Vancouver:
Copy. Safety and efficacy of nanocurcumin as addon therapy to riluzole in patients with amyotrophic lateral sclerosis: A pilot randomized clinical trial. NEUROTHERAPEUTICS[Internet]. 2018;15(-):430-438. Available from: https://sid.ir/paper/726327/en
IEEE:
Copy, “Safety and efficacy of nanocurcumin as addon therapy to riluzole in patients with amyotrophic lateral sclerosis: A pilot randomized clinical trial,” NEUROTHERAPEUTICS, vol. 15, no. -, pp. 430–438, 2018, [Online]. Available: https://sid.ir/paper/726327/en